Skip to main content

Forbion European Acquisition Corp. (FRBN)

NASDAQ Stock Market Financial Services Shell CompaniesView data quality →
25.6Poor

ValueMarkers Composite Index

Top 0%#44,708 of 44,714

DCF data not available

Piotroski
0/9
Weak
Beneish
-
Altman
-
DCF Value
-
N/A
ROIC
-
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Forbion European Acquisition Corp. (FRBN) — VMCI valuation read

FRBN screens at VMCI 26/100, a 24-point gap below the Financial Services sector median (50). For a mid-cap Forbion European Acquisition Corp. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

FRBN has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: FRBN trades at 14.0x earnings, 22% below the Financial Services median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Financial Services group. Quality: ROIC of 12.0% sits 2.0pp above the Financial Services median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 2.2x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for Forbion European Acquisition Corp..

FRBN fell 2.3% over the trailing 7 days, with a -13.3% read on a 30-day basis.

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.

CEO: Jasper M. BosUSforbion.com/en/feac

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in FRBN’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.